
Overview
Vincent Nacinovic is an associate in the Corporate practice of Paul Hastings and is based in the firm's Paris office. His practice focuses on mergers & acquisitions, private equity transactions, and other corporate transactions.
Education
Master's degree in International Law and Management from the business school ESCP Europe in 2015.
Master's degree in Business Law (D.J.C.E.), University of Cergy-Pontoise in 2014.
news
Involvement
Admitted to the Paris Bar since 2016
Recent Representations
Advising Andera Partners and the management team in connection with the LBO of Skill & You structured by IK Investment Partners.
Advising Sagard in connection with the OBO of Asobo Studio.
Advising the management of Odigo Group in connection with the LBO structured by Apax Partners.
Advising the Founder in connection with the LBO of Cleenven Group structured by Vespa Capital.
Advising Antin Infrastructure Partners in connection with the sale of Inicéa to Korian Group.
Advising Isai Expansion in connection with the LBO of Vitalliance Group.
Advising Argon & Co and its founders in connection with a MBO structured by Ardian Growth.
Advising Keensight Capital in connection with the LBOs of Sogelink Group and of Smile Group.
Advising Andera Partners - Actomezz, Tikehau and Bpifrance in connection with the LBO of Ellisphère Group.
Advising 21 Invest in connection with the LBO of FMA Assurances.
Advising B & Capital in connection with the LBOs of HR Team Group and of Steliau Technology Group.
Advising the financial investor in connection with the LBO of Milexia Développement.
Advising the shareholders of Circet in connection with the sale of Circet Group to Advent.
Advising CM-CIC Investissement and Circet in connection with the LBU of CapCom Group.
Advising Antin Infrastructure Partners in connection with the acquisition of Almaviva Group.
Advising the shareholders of OneAccess in connection with the disposal of the company to Ekinops.
Advising the Management of Maxibazar in connection with the LBO of Maxibazar.
Advising Eurazeo-PME in connection with the takeover of In'Tech Medical Group.
Advising Eurazeo in connection with the Fonroche Group spin-off and the subsequent sale of a 50% stake to Infravia.